Cath Lab Digest

What can firsthand experience reveal about the new Shockwave C2 Aero? CLD's Partner Spotlight features practical insights into how #ShockwaveC2Aero is being used to approach coronary calcium modification in real-world cases. Find more: hubs.ly/Q04gkfWD0 @ShockwaveIVL

What does a high-functioning hybrid OBL/ASC look like in practice? Timothy Dao, MD, and Rikesh Patel, MD, share how HeartPlace is using careful case selection, efficiency, and safety to expand outpatient cardiovascular care in Texas. hubs.ly/Q04fqxBT0 #cardiotwitter #ASC

Microplastics as Triggers of Immunothrombosis: Linking Environmental Exposure to Cardiovascular Events Small particles, serious consequences. Emerging research links everyday exposure to immune-driven clotting and cardiovascular risk. Learn more: hubs.ly/Q04fskMt0 @hmpVDM

Advanced heart failure specialist Matthew Gonzalez, MD, shares practical insights for using the CardioMEMS™ HF System, made by Abbott, in real-world practice. Read more: hubs.ly/Q04dz6BV0 #CardioMEMS #cardiotwitter @AbbottCardio #HeartFailure

What happens when insurance decisions stand in the way of timely care for chronic limb-threatening ischemia? Lata et al share a case; commentary by Nanjundappa et al. Read more: hubs.ly/Q04f8dSs0 #medtwitter @InvasiveCardiol @hmpVDM

Coronary interventions are moving into ASCs. What’s your system’s plan? Marc Toth and Derek Mitzel outline why an ambulatory strategy now needs clear case selection, escalation pathways, staffing, and a system-wide access + growth playbook. hubs.ly/Q049KkJP0 #cardiotwitter

RCT data are coming for pelvic vein embolization. Co-PI @RonaldWinokurMD on the EMBOLIZE trial: venography vs venography + ovarian/pelvic vein embolization for pelvic venous disease pelvic pain (pain + QoL). hubs.ly/Q0494gJR0 @PenVascular

Ultra-high-pressure balloon strategy in complex PCI: @KAlaswadMD shares how the OPN NC (35 atm) can tackle resistant calcium/underexpanded stents, with trial data (eg, VICTORY) supporting stent expansion comparable to IVL in selected cases. hubs.ly/Q04clvfb0

Leapfrog is expanding ASC public reporting: nearly 4,000 centers will be rated starting late July 2026, using CMS measures, accreditation-verified standards, and a redesigned ASC Survey 2.0. hubs.ly/Q049K9Ms0 #cardiotwitter #cardiology #medtwitter

Daniel Aboyeji, RN, BSc, asks: During arrest from abrupt unprotected left main occlusion, is a brief “controlled pause” in CPR (<1-2 min) ever justified to regain guide/wire position and restore flow? @MortonKern + colleagues weigh in hubs.ly/Q04bpWsg0 #cardiotwitter

Ultra-high-pressure balloon strategy in complex PCI: @KAlaswadMD shares how the OPN NC (35 atm) can tackle resistant calcium/underexpanded stents, with trial data (eg, VICTORY) supporting stent expansion comparable to IVL in selected cases. hubs.ly/Q0494XS90

Tonight at 7 PM ET. If you treat calcified PAD—or help run a PAD program—join this live 60-minute webinar on IVL’s clinical role and the practical economic/operational considerations that drive adoption. Register: hubs.ly/Q044PGJY0

If you’ve been meaning to register, here’s the nudge: this is a 60-minute, decision-relevant session—built around what determines real-world adoption (not theory). IVL in PAD • Live 3/25 at 7 PM ET Save your seat: hubs.ly/Q044PCrl0

Built for clinicians + program leaders. ➔ Clinicians: navigate system constraints. ➔ Admins: understand operational/economic drivers of adoption. IVL in PAD live webinar: 3/25, 7 PM ET (60 min). hubs.ly/Q044PycM0

Rural access win: Amanda Ryan, DO, shares how her hybrid OBL/ASC in New Mexico is cutting multi-hour travel for cardiac and vascular care, and what it takes to build a mission-driven program in a 3-county region. hubs.ly/Q045yJrf0

Presented at EuroPCR, EMPOWER CAD tested an intravascular lithotripsy-first PCI strategy in women with severely calcified CAD, showing 86.9% procedural success at 30 days + 0.2% serious angiographic complications. Learn more: hubs.ly/Q045d_Bb0 #cardiotwitter @ShockwaveIVL

Coronary calcium: Margaret McEntegart, MD, on why IVL can be safe, effective, and cost efficient, with analyses suggesting lower per-case costs vs rotational atherectomy. hubs.ly/Q045dYGx0 #cardiotwitter @mbmcentegart @ShockwaveIVL

How a Virginia cardiology group built an ASC around EP + peripheral first, then planned ahead for a cath lab with CON approval. Practical lessons on staffing, workflow, and patient selection from Ann E. Honeycutt, MSN. hubs.ly/Q045yJWk0

Treat calcified PAD? “Economics” often determines what gets adopted. Get practical IVL in PAD insights: care pathways + reimbursement/coding/coverage + implementation. Live 3/25, 7 PM ET: hubs.ly/Q044Pvjy0

Excited to share this discussion from #CRT2025 with @CathLabDigest on CMD and the critical role of cath lab staff in diagnosis and care Just in time for #CRT2026 @CRT_meeting 🎥 Watch here: hmpgloballearningnetwork.com/site/cathlab/v… #Cardiology #CathLab #CMD #ANOCA